CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Lisheng Pharmaceutical Company Limited Company Snapshot
Tianjin Lisheng Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Lisheng Pharmaceutical Company Limited with three other companies in this sector in CHINA : Lionco Pharmaceutical Group Co Ltd (2019 sales of 1.64 billion Chinese Renmimbi [US$241.15 million] of which 42% was Anti-Infection), Yipinhong Pharmaceutical Co Ltd (1.64 billion Chinese Renmimbi [US$241.50 million] of which 78% was Pharmaceutical Manufacturing), and Guilin Sanjin Pharmaceutical Co Ltd (1.64 billion Chinese Renmimbi [US$241.93 million] of which 90% was Proprietary Chinese medicine).

Sales Analysis. During the year ended December of 2019, sales at Tianjin Lisheng Pharmaceutical Company Limited were 1.62 billion Chinese Renmimbi (US$238.24 million). This is an increase of 7.4% versus 2018, when the company's sales were 1.50 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Tianjin Lisheng Pharmaceutical Company Limited (and since 2014, sales have increased a total of 109%). Sales of Tablet saw an increase of 11.4% in 2019, from 1.17 billion Chinese Renmimbi to 1.30 billion Chinese Renmimbi. Not all segments of Tianjin Lisheng Pharmaceutical Company Limited experienced an increase in sales in 2019: sales of Other fell 26.4% to 17.28 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Tianjin Lisheng Pharmaceutical Company Limited also experienced decreases in sales in Injection (down 6.4% to 182.73 million Chinese Renmimbi) and Capsule (down 2.3% to 115.39 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Lisheng Pharmaceutical Company Limited
  Stock Performance Chart for Tianjin Lisheng Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 25.52
(Figures in Chinese Renmimbi)
1 Week 0.8%   13 Weeks -7.5%  
4 Weeks -2.1%   52 Weeks -0.6%  
 
Tianjin Lisheng Pharmaceutical Company Limited Key Data:
  Ticker: 002393 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,615,276,373
(Year Ending Jan 2020).
Employees: 1,679
  Currency: Chinese Renmimbi Market Cap: 4,656,251,396
  Fiscal Yr Ends: December Shares Outstanding: 182,454,992
  Share Type: A Gu Closely Held Shares: 103,911,899
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.